The BNT162b2 vaccine was shown to have 95% efficacy against coronavirus disease 2019 (Covid-19). 1 To date, the two-dose vaccine protocol has not been approved in Israel for persons previously ...
It has been one year since the outbreak of COVID-19, but there is still an increasing number of confirmed cases. The epidemic situation is still challenged all over the world. The effective drug ...
Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern pose a challenge to the effectiveness of current vaccines. A vaccine that could prevent infection caused by ...
In a recent study published on the bioRxiv* preprint server, researchers in China present a rational approach for identifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) ...
From the start of the COVID-19 pandemic, many of researchers’ nagging questions involved trying to understand what constitutes immunity to future infections. People who had been infected by the virus ...
Antibodies have become an integral part of research and medicine. Therapeutic applications of antibodies began to emerge following the publication of Köhler and Milstein’s groundbreaking 1975 paper in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results